Results 181 to 190 of about 9,042 (190)
Some of the next articles are maybe not open access.
cDC1 Prime and Are Licensed by CD4+ T Cells to Induce Anti-Tumour Immunity
Nature, 2020Robert D. Schreiber +2 more
exaly
Immunoactive nanoparticle boosted cDC1 for in situ cancer immunotherapy
PURPOSE: Cancer immunotherapy, which aims to stimulate the immune system to induce antigen specific immune responses against cancers, has emerged as a promising approach for cancer intervention. However, eliciting an effective antitumor immune response is hindered by the scarcity of appropriate antigen-presenting cells (APCs) and their impaired ...openaire +1 more source
Differential Chemokine Receptor Expression and Usage by Pre-cDC1 and Pre-cDC2
Immunology and Cell Biology, 2018Quintin Lee +2 more
exaly
cDC1s license CD8+ T cell-mediated neurodegeneration
Nature Reviews ImmunologyJonathan K, Monteiro +1 more
openaire +2 more sources

